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C E L L U L A R  N E U R O S C I E N C E
Macrophage centripetal migration drives spontaneous 
healing process after spinal cord injury
Kazu Kobayakawa1,2,3,4, Yasuyuki Ohkawa5, Shingo Yoshizaki1,2, Tetsuya Tamaru1,2, 
Takeyuki Saito2, Ken Kijima1,2, Kazuya Yokota2, Masamitsu Hara2,3, Kensuke Kubota2,4, 
Yoshihiro Matsumoto2, Katsumi Harimaya2, Keiko Ozato6, Takahiro Masuda7, Makoto Tsuda8, 
Tomohiko Tamura9, Kazuhide Inoue7, V. Reggie Edgerton3, Yukihide Iwamoto10, 
Yasuharu Nakashima2, Seiji Okada1*
Traumatic spinal cord injury (SCI) brings numerous inflammatory cells, including macrophages, from the circulating 
blood to lesions, but pathophysiological impact resulting from spatiotemporal dynamics of macrophages is unknown. 
Here, we show that macrophages centripetally migrate toward the lesion epicenter after infiltrating into the wide 
range of spinal cord, depending on the gradient of chemoattractant C5a. However, macrophages lacking interferon 
regulatory factor 8 (IRF8) cannot migrate toward the epicenter and remain widely scattered in the injured cord 
with profound axonal loss and little remyelination, resulting in a poor functional outcome after SCI. Time-lapse 
imaging and P2X/YRs blockade revealed that macrophage migration via IRF8 was caused by purinergic receptors 
involved in the C5a-directed migration. Conversely, pharmacological promotion of IRF8 activation facilitated 
macrophage centripetal movement, thereby improving the SCI recovery. Our findings reveal the importance of 
macrophage centripetal migration via IRF8, providing a novel therapeutic target for central nervous system injury.
INTRODUCTION
Spinal cord injury (SCI) is a devastating disorder resulting in perma-
nent motor/sensory dysfunction (1). Mechanical injury causes bleed-
ing and disruption of the blood–spinal cord barrier, followed by the 
infiltration of circulating cells such as macrophages and neutrophils 
(2). In the acute phase of SCI, these cells secrete tumor necrosis 
factor–, interleukin-1, and inducible nitric oxide synthase, induc-
ing a secondary injury cascade that leads to demyelination and the 
loss of neuronal fibers around the originally injured site with dete-
rioration of postinjury motor functional recovery (1, 3–6). However, 
after the acute phase of SCI, little is known about the behavior of 
these cells.
In the post-acute phase, long-distance axonal retraction from the 
initial site of injury (called axonal dieback) occurs, and infiltrating 
macrophages touching axons exacerbate this axonal injury (7, 8). 
However, in this phase, spontaneous tissue repair such as remyelina-
tion and axonal regeneration also occurs with partial motor recovery 
(1, 9, 10). To understand such complex pathophysiology, compre-
hensive screenings such as RNA sequencing (RNA-seq) can extract 
the factors involved in the recovery or progression of diseases (11–13).
In this study, we developed a time-course RNA-seq analysis pro-
tocol for SCI based on an established strategy (14), identifying a tran-
scriptional factor, interferon regulatory factor 8 (IRF8), as a signifi-
cantly increased factor during the recovery phase. We observed that 
infiltrating macrophages usually showed active migration to the 
injured site, but a lack of such macrophage migration in IRF8−/− mice 
had a negative impact on both damaged central nervous system (CNS) 
tissue and motor improvement after SCI. Furthermore, time-lapse 
imaging clarified the mechanism underlying macrophage migration 
via complement component C5a. Last, we showed that activating 
IRF8 contributed to macrophage migration and functional improve-
ment, indicating a potential novel therapeutic intervention for SCI.
RESULTS
IRF8 expression is increased in the spinal cord after SCI
Although traumatic SCI results in residual motor/sensory paralysis, 
spontaneous functional recovery occurs to some extent after injury 
(15). In this study, we produced a contusion SCI (70 kilodynes) at 
the thoracic level of wild-type (WT) mice using a highly reproduc-
ible computer-controlled impactor and confirmed considerable 
recovery of the motor function for 2 weeks after SCI (15). To deter-
mine the genes that significantly increased expression levels in 
motor recovery phase, we performed a time-course genome-wide 
expression analysis. The heat map visually showed dynamic changes 
in expression of all genes at 4 to 14 days postinjury (dpi) (Fig. 1A). 
We initially expected that the genes involved in neural tissue regen-
eration or CNS repair would be enriched in the recovery phase of 
SCI. However, a gene ontology (GO) term analysis indicated that 
the genes involved in immune response, leukocyte activation, and 
chemotaxis were highly enriched, letting us further focus on the 
gene expression of leukocytes in the recovery phase of SCI (Fig. 1B). 
In the leukocyte-related genes, significant differences in the expres-
sion of IRF8, glycoprotein 49 A (Gp49a), and sulfatase 1 (Sulf1) 
were determined at 7 dpi by Cuffdiff (Fig. 1C) (16). Of these, the 
IRF8 expression was consistently and significantly increased at 
14 dpi (Fig. 1, D and E), which was further confirmed by a quantitative 
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polymerase chain reaction (qPCR) analysis (Fig. 1F). We therefore 
focused on the IRF8 function during SCI recovery.
IRF8 is selectively expressed in CD68+ cells after SCI
Macrophages [CD68+ in injured spinal cord (6)] express IRF8. To 
identify IRF8 localization, we performed an immunohistochemical 
analysis of the injured spinal cord. Whereas no IRF8 expression was 
detected in polymorphonuclear (PMN)–positive neutrophils, CD3+ 
T cells, glial fibrillary acidic protein (GFAP)–positive astrocytes, neuronal 
nuclei (NeuN)–positive neurons, or glutathione S-transferase (GST)––
positive oligodendrocytes, all IRF8+ cells were CD68+ in the injured 
cord (Fig. 2, A to H). These results were confirmed by a PCR analysis with 
selectively isolated mRNA from these cells using flow cytometry or 
laser microdissection (LMD) (Fig. 2I). Notably, at 4 dpi, IRF8 was 
located in the cytoplasm and nucleus of CD68+ cells but localized in 
the nucleus at 7 dpi, suggesting that IRF8 nuclear translocation and 
its transcriptional activity were enhanced at 7 dpi (Fig. 2, B and C).
IRF8 is crucial for the epicenter-directed macrophage 
migration in the injured spinal cord
To investigate the role of IRF8 in macrophage behavior after SCI, 
we first performed quantitative analysis of infiltrating macrophages 
in WT and IRF8−/− mice using the cell sorter (15, 17). As previously 
described, CD45+ cells obtained from the spinal cord tissue were 
subdivided into three populations on the basis of expression of the 
surface markers, and the CD11bhigh/Ly6Gnega/CD45high population 
was isolated as infiltrating macrophages (4, 15). The quantitative 
analysis and gene expression analysis demonstrated that IRF8 did 
not affect the cell number and polarization of infiltrating macro-
phages after SCI (Fig. 3, A and B, and fig. S1) (3, 6, 18). Next, we 
performed immunohistochemical analysis of injured spinal cords 
of these mice and observed that the location of CD68+ cells in the 
injured cord of WT mice gradually shifted toward the lesion epicenter 
from 4 to 42 dpi (Fig. 3, C and D). However, we found that the CD68+ 
cells of IRF8−/− mice remained widely scattered over the injured cord 
Fig. 1. A time-course RNA-seq analysis reveals prominent IRF8 expression in the spinal cord during the recovery phase after SCI. (A) A heat map showing gene 
expression changes in the injured cord at 4, 7, and 14 dpi. Data from the samples of injured cords were normalized to those of uninjured cords. (B) GO term analysis of 
overexpressed (>10-fold change) genes in the RNA-seq analysis of the injured cord (7 dpi) compared to those of the uninjured cord. Lists show the top nine GO terms 
obtained ranked by P value (Fisher’s exact test with Benjamini-Hochberg correction). (C) Volcano plot of the gene expression differences between the injured cord (7 dpi) 
and uninjured cord. Red or blue dots indicate significantly up-regulated or down-regulated genes, respectively. (D) Wiggle plots showing the coverage of each exon for 
IRF8 before injury and at 4, 7, and 14 dpi. Ref-seq, reference sequencing. (E) Ratio of the fragments per kilobase of exon per million mapped sequence reads (FPKM) value 
of IRF8 to the mean FPKM value of all expressed genes at each time point after SCI. (F) Significantly increased mRNA expression of IRF8 analyzed with qPCR in spinal cords 
before and after injury (n = 5 per each time point). The data shown in (A) to (E) are representative of four samples per time point. *P < 0.05 and **P < 0.001, one-way anal-
ysis of variance (ANOVA) with Dunnett’s test for multiple comparisons against the uninjured control group (F). The data are presented as the means ± SEM.
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until 42 dpi (Fig. 3, C and D). A histological quantitative analysis 
confirmed that the craniocaudal ranges of CD68+ cells of IRF8−/− 
mice were significantly broader than those of WT mice at 7, 14, and 
42 dpi, respectively (Fig. 3E). These results suggested that the infil-
trating WT macrophages migrated toward the epicenter, while the 
IRF8−/− macrophages did not.
Peripheral blood–derived macrophages migrate toward 
epicenter after SCI via IRF8
Because both peripheral blood–derived macrophages and spinal 
cord–resident microglia are CD68+/IRF8+ and immunohistologically 
indistinct from one another (4, 8, 19), the IRF8-dependent migra-
tion of CD68+ cells might be due to resident microglia. To investigate 
this issue, we developed two bone marrow chimeric mice models: 
microglial IRF8–deficient and macrophagic IRF8–deficient chimeric 
mice, as previously described (fig. S2A) (20). These chimeric mice 
revealed that IRF8-dependent migration of CD68+ cells is due to 
microphages, not to microglia, and that microglial IRF8 had no sig-
nificant influence on functional outcomes after SCI (fig. S2, B to F). 
Therefore, we further explored the influence of IRF8 in peripheral 
blood–derived macrophages on the pathophysiology after SCI.
To directly test the migration ability of WT and IRF8−/− macro-
phages in vivo, we performed one-shot injection of IRF8+/+-enhanced 
green fluorescent protein–positive (EGFP+) or IRF8−/−-EGFP+ CD11bposi/
Ly6Gnega/CD115posi peripheral blood– derived monocytes, which differ-
entiate to macrophages in injured spinal cords (21), into 2 mm rostral 
to the epicenter of the WT spinal cord immediately after SCI (fig. S3). 
Analyzing the time-course sections of these injured cords, we found 
that the injected EGFP+- IRF8+/+ CD68+ cells migrated toward the 
epicenter of the injured cord (Fig. 3, F and G). In contrast, the in-
jected EGFP+-IRF8−/− CD68+ cells remained at the site of injection 
until 14 dpi (Fig. 3, F and G). These results indicated that WT 
macrophages actually migrate toward the epicenter, while migra-
tion of IRF8−/− macrophages is critically impaired. However, there 
remained a possibility that some WT macrophages far from the epi-
center might have disappeared, with other macrophages newly in-
filtrating near the epicenter. To clarify this issue, we performed 
daily intravenous injection of EGFP+ monocytes after SCI (Fig. 3H). 
When IRF8+/+-EGFP+ or IRF8−/−- EGFP+ monocytes were intrave-
nously injected from 1 to 3 dpi, they infiltrated to spinal cords; how-
ever, the monocytes injected intravenously after 4 dpi did not infil-
trate in the injured cord from the peripheral blood (Fig. 3I and fig. 
S4). Together with the result of spinal injection of monocytes, we 
found that the translocation of macrophages in the injured spinal 
cord was not due to later infiltration into the central region but due 
to the actual migration toward the epicenter via IRF8.
Fig. 2. IRF8 is expressed in CD68+macrophages after SCI. (A) Representative images of immunofluorescent staining of spinal cord with CD68 (green) and IRF8 (red) in 
WT mice at 4 and 7 dpi. The asterisks indicate the lesion epicenter. (B) CD68 (green) and IRF8 (red) double-positive macrophages in the perilesional areas. The nuclei were 
counterstained with Hoechst 33258 dye (blue). Selective localization of IRF8 in the nuclei of macrophages was observed at 7 dpi (bottom). All IRF8-expressing cells were 
CD68+. (C) Fluorescence ratio (Fl. ratio) of nuclear IRF8 to cytosolic IRF8 (n = 30 cells per group). (D to H) Double immunostaining of IRF8 with PMN, CD3, GFAP, NeuN, and 
GST-. (I) The IRF8 expression examined by reverse transcription PCR (RT-PCR) in selectively isolated macrophages, neutrophils, reactive astrocytes, and neurons. Among 
these cells, the IRF8 expression was observed only in macrophages. The data shown in (I) are representative of three samples from three mice/each cell fraction. Images 
shown in (A), (B), and (D) to (H) are representative of eight sections per four mice. The images were obtained from two independent experiments. Scale bars, 500 m (A), 20 
m (E and G), and 10 m (B, D, F, and H). **P < 0.005, Wilcoxon rank-sum test. The data are presented as means ± SEM. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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Fig. 3. IRF8 is required for macrophage migration toward the epicenter in the injured spinal cord during the recovery phase. (A) CD45-gated cells in the injured cord 
were divided into CD11b+/CD45high/Ly6G− infiltrating macrophages. The cell numbers of these macrophages in the injured cord of WT/IRF8−/− mice were quantitatively 
counted using the FACS software program. FITC, fluorescein isothiocyanate; PE, phycoerythrin; SSC, side scatter; APC, allophycocyanin. (B) The cell numbers of macro-
phages in the injured cord of IRF8−/− mice were comparable to those of WT mice after SCI (n = 6 per group). Although IRF8−/− mice generate reduced numbers of mono-
cytes/macrophages (66), these results indicate that macrophage infiltration into the injured spinal cord does not require IRF8. n.s., not significant. (C) Change in the 
distribution of CD68+ macrophages over time. The location of macrophages shifted toward the lesion epicenter from 4 to 14 dpi after injury in WT mice, whereas the 
macrophages of IRF8−/− mice remained widely scattered in the injured cord. The fine lines indicate the outlines of the spinal cords. Asterisk indicates the epicenter of the lesion. 
(D) Distribution of macrophages in WT or IRF8−/− mice at 42 dpi. The fine lines indicate the outlines of the spinal cords. Asterisk indicates the epicenter of the 
lesion. (E) Comparison of the craniocaudal distribution of macrophages in injured cords between WT and IRF8−/− mice (n = 8 WT, 7 IRF8−/− mice per group at each time point, respectively). 
(F) EGFP+-IRF8+/+ (left) or EGFP+-IRF8−/− (right) monocytes isolated from the peripheral blood of EGFP+-IRF8+/+ or EGFP+-IRF8−/− mice as EGFPposi/CD11bposi/Ly6Gnega/CD115posi 
monocytic population (fig. S3), respectively, were injected into 2 mm rostral to the epicenter of the injured spinal cord of WT mice once immediately after SCI. Representa-
tive images of the immunofluorescent staining of spinal cord injected with these monocytes after SCI. Tp; transplantation of EGFP+ monocytes. The fine broken lines indicate 
the outlines of the spinal cords. The coarse broken lines indicate the area of the EGFP−/CD68+ host macrophages. The asterisks indicate the epicenters of injured spinal 
cord. The arrowheads indicate the injection point of the EGFP+ macrophages. Inset: High-magnification image. The nucleus was counterstained with Hoechst 33258 dye 
(blue). Scale bar, 20 m. The images shown are representative of six slides from three mice per time point per group. (G) Distances of EGFP+-IRF8+/+ or EGFP+-IRF8−/− macro-
phages from the epicenter at each time point (n = 6 sections/three mice per each time point per group). (H) Schematic representation of intravenous (I.V.) injection of EGFP+- 
IRF8+/+ or EGFP+-IRF8−/− monocytes after SCI. EGFP+-IRF8+/+ or EGFP+-IRF8−/− monocytes were daily injected intravenously from 1 to 3, 4 to 6, or 7 to 13 dpi. (I) Quantitative 
analysis of the infiltrating EGFP+ macrophages in the injured cord of mice intravenously injected with EGFP+ macrophages from 1 to 3, 4 to 6, or 7 to 13 dpi (n = 4 sections/
four mice per group) (see also fig. S4). The images shown in (C) and (D) are representative of eight or seven slides from eight WT/seven IRF8−/− mice per each time point. Scale 
bars, 500 m (C, D, and F). *P < 0.05 and **P < 0.005, Wilcoxon rank-sum test (B), two-way repeated-measures ANOVA with the Tukey-Kramer post hoc test (E and I), and ANO-
VA with the Tukey-Kramer post hoc test (G). The data are presented as means ± SEM (B, E, G, and I).
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The widely scattered IRF8−/− macrophages caused the 
profound neural damage and the poor functional recovery 
after SCI
Given that infiltrating macrophages in touch with axons directly exacer-
bate axonal dieback (8), we next investigated the 5-hydroxytryptamine 
(5HT)–positive axons in IRF8−/− mice after SCI and found that IRF8−/− 
mice had significantly fewer 5HT+ axons than WT mice at 42 dpi 
(Fig. 4, A and B, and fig. S5, A to E), suggesting that a wide range of 
scattered IRF8−/− macrophages may be involved in this profound 
axonal loss. Because the spared axons are needed for remyelination 
after SCI (22), Luxol fast blue (LFB) staining (myelin sheath stain-
ing) was performed. Accompanied with the few 5HT+ axons and 
widely scattered macrophages, IRF8−/− mice showed a significantly 
decreased LFB+ area compared with WT mice at 42 dpi, 
although the LFB+ area in IRF8−/− mice was comparable to that 
in WT mice both before injury and at 7 dpi, respectively, in-
dicating remyelination disorder after SCI in IRF8−/− mice 
(Fig. 4, C to E, and fig. S5, F to I). The myelin sheath area had 
a strong, negative correlation with the area of CD68+ cells, support-
ing the role of widely scattered IRF8−/− macrophages in axonal loss 
and subsequent remyelination disorder (Fig. 4F). In addition, migra-
tion of astrocytes and astroglial formation were impaired, and neu-
ronal loss was exacerbated in IRF8−/− mice compared with WT mice 
after SCI (fig. S5, J to Q). The area of demyelination, astrocytes 
migration, glial scar formation, and neuronal loss after SCI are as-
sociated with decrease in functional recovery (4, 9, 23). Here, 
IRF8−/− mice exhibited worse functional outcomes after SCI compared 
with WT mice, as measured by the Basso Mouse Scale (BMS) score, 
foot print analysis, and grip walk test (Fig. 4, G to J) (24, 25).
To investigate the possibility that IRF8−/− macrophages might 
modulate the plasticity after SCI through cytokine expression, we 
performed RNA-seq analysis of both WT and IRF8−/− mice. Pathway 
analysis detected significantly enriched KEGG (Kyoto Encyclopedia 
of Genes and Genomes) pathways related to cytokines after SCI in 
WT mouse, but the RNA-seq analysis and gene expression analysis in 
macrophages showed comparable expression levels of these cyto-
kines between WT and IRF8−/− genotypes, indicating that IRF8 did 
not determine cytokine expression levels in macrophages or spinal 
cords (figs. S6 to S15) (3, 26). These findings indicated that IRF8−/− 
macrophages caused the poor histopathological outcomes leading 
to the worse functional recovery due to impaired migration toward 
the epicenter after SCI.
IRF8 influences the migration capability of macrophages in 
the gradient of complement component C5a
We next explored what factors attract the macrophages centripetally. 
To date, complement component C5a, fractalkine, and Reg3 have 
been reported as chemoattractants for macrophages (12, 27, 28). An 
immunohistochemical analysis revealed a strong C5a expression in 
the epicenter (Fig. 5A). Therefore, we further analyzed the C5a gra-
dient and found that the C5a expression gradually increased when 
approaching the epicenter, suggesting that C5a at the epicenter at-
tracted the macrophages (Fig. 5B). To verify the role of C5a on macro-
phage migration, C5a was ectopically injected rostral and caudal to 
the epicenter from 4 to 7 dpi. The macrophages migrated toward 
both C5a injection sites and the epicenter and were widely scattered, 
directly indicating that epicenter-directed macrophage migration was 
dependent on the C5a concentration (Fig. 5, C and D). Accompanied 
with widely scattered macrophages, the number of NeuN+ neurons 
in the mice with C5a injection after SCI was significantly reduced 
compared with that with phosphate-buffered saline (PBS) injection 
(fig. S16, A to C). In addition, functional recovery was deteriorated 
by the C5a injection (fig. S16D). These results indicated the detri-
mental effect of the impaired migration of infiltrating macrophages 
after SCI. To investigate the IRF8−/− macrophage migration with C5a, 
time-lapse phase-contrast imaging was performed. In the stable 
C5a gradient, WT macrophages rapidly migrated toward higher 
C5a concentrations with a strong directionality, represented by the 
chemotaxis index (Fig. 5, E to H, and movie S1). However, IRF8−/− 
macrophages showed extraordinarily low displacement and de-
creased directionality to C5a (Fig. 5, E to H, and movie S2). These 
results indicated that the IRF8−/− macrophages failed to migrate 
toward the epicenter in the injured cord due to impaired directional 
movement toward C5a at the epicenter. To approach the mechanisms 
behind the C5a-directed macrophage migration via IRF8 signaling, 
we first investigated receptors of C5a, but the expression levels of 
C5ar1 and C5ar2 (coding the receptors of C5a) were comparable 
between WT and IRF8−/− macrophages (fig. S17) (29, 30). Next, we 
analyzed the purinergic receptor pathway because macrophages 
release adenosine triphosphate (ATP) in C5a gradient in a paracrine 
manner, and ATP and its degradation products (adenosine diphos-
phate and adenosine) bind to the purinergic receptors to drive macro-
phage migration by inducing lamellipodial membrane protrusions 
(28). IRF8−/− macrophages exhibited significantly lower expression 
levels of purinergic receptors than IRF8+/+ macrophages (Fig. 5I), 
suggesting IRF8 control macrophage migration via purinergic recep-
tors expression. To further investigate whether purinergic receptors 
have a significant role in macrophagic migration after SCI, we blocked 
purinergic receptor signaling using inhibitors after SCI. Following 
the previous study demonstrating that triple and cocktail block of 
purinergic receptors could inhibit macrophagic migration (28), we 
injected AR-C69931MX (P2Y12R inhibitor), AR-C118925XX 
(P2Y2R inhibitor), 8-SPT (A2a-A3 inhibitor), MRS-2179 (P2Y1R 
inhibitor), and NF-449 (P2X1R and P2X4R inhibitor) into spinal cord 
of WT mice from 4 to 12 dpi. The injection with AR-C69931MX, 
AR-C118925XX and 8-SPT (triple block) inhibited migration 
of macrophages after SCI (Fig. 5, J and K). Moreover, we found 
that the migration failure of macrophages with AR-C69931MX, 
AR-C118925XX, 8-SPT, MRS-2179, and NF-449 (cocktail block) 
was severer than that with triple block (Fig. 5, J and K). These 
results indicate that IRF8 regulates the expression of purinergic 
receptors that is important for macrophagic centripetal migration 
after SCI.
Activation of IRF8 signaling enhanced epicenter-directed 
migration of macrophages and functional recovery after SCI
IRF8 was activated and translocated into nuclei of macrophages at 
7 dpi with epicenter-directed migration (Figs. 2 and 3). To further 
investigate whether the activation of IRF8 promotes macrophage 
migration, EGFP+ macrophages with IRF8 activation were isolated 
from the injured cords of chimeric mice with EGFP+ IRF8+/+ macro-
phages and EGFP− IRF8+/+ microglia at 7 dpi, and EGFP+ macrophages 
without IRF8 activation were isolated from the chimeric mice at 
4 dpi; we then transplanted them into WT spinal cords immediately 
after SCI and observed that macrophages with IRF8 activation 
migrated faster than those without IRF8 activation and were more 
tightly compacted than the host macrophages at 7 days after trans-
plantation (Fig. 6, A to C, and fig. S18). These results indicated that 
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IRF8 activation accelerated epicenter-directed macrophage 
migration.
These findings led us to explore whether enhancing IRF8 acti-
vation could improve the SCI recovery. To test this, we adminis-
tered a combination of interferon- (IFN-) and lipopolysaccharide 
(LPS), which strongly activates IRF8 (31). Before this in vivo exper-
iment, we evaluated the efficacy of the combination in vitro. Without the 
combination, most of the IRF8 was located in the cytoplasm; how-
ever, immediately after stimulation, IRF8 nuclear translocation was 
observed accompanied by significantly increased gene expression 
of purinergic receptors (Fig. 6, D to F). For the in vivo combination 
administration, spinal injections were performed after 48 hours post-
injury (hpi) (Fig. 6G) to avoid possible exacerbation of acute in-
flammatory reaction after SCI, which peaked between 3 and 12 hours 
hpi and thereafter resolved by 24 hpi, as reported previously (24, 32). 
Actually, we did not observe any harmful effects of this combina-
tion injection such as systemic inflammation and neuropathic pain 
after SCI (19, 33), supporting the feasibility of this therapy (fig. S19, 
Fig. 4. Widely scattered macrophages in IRF8−/−mice caused the widespread lesion and the poor functional recovery after SCI. (A) 5HT (white) and CD68 (green) 
staining of the injured cords of WT and IRF8−/− mice at 42 dpi (representative images of seven sections from seven mice per group). (B) Quantification of the 5HT+ area per 
4.0 × 105 m2 at 42 dpi (n = 7 sections/seven mice per group). (C) LFB staining showed a greater demyelinated lesion (arrows) area in IRF8−/− mice than in WT mice at 42 
dpi. The asterisk indicates the lesion epicenter. (D) Immunohistochemical staining showed CD68+ macrophages located in the LFB-negative demyelinated area of the 
serial section shown in (C). The asterisk indicates the lesion epicenter. (E) Quantification of the area of LFB+ myelin at 42 dpi (n = 6 per group). (F) A linear regression 
analysis showing the negative correlation between the CD68+ and LFB+ areas at 42 dpi ( = −2.49; 95% confidence interval, −3.19 to −1.79). (G) Time course of the func-
tional recovery of the BMS score after SCI (n = 8 per group). (H) A footprint analysis performed at 42 dpi showed that IRF8−/− mice were unable to consistently step. (I) 
Quantification of the footprint analysis after SCI showing significantly worse motor functions in IRF8−/− mice than in WT mice at 42 dpi (n = 8 per group). (J) Scores for the 
grip walk test in each mouse at 42 dpi. The images shown in (C) and (D) are representative of six slides from six mice per each group. Scale bars, 50 m (A) and 500 m (C 
and D). *P < 0.05 and **P < 0.005, Wilcoxon rank-sum test (B, E, I, and J) and two-way repeated-measures ANOVA with the Tukey-Kramer post hoc test (G). The data are 
presented as means ± SEM (B, E, G, and I).
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Fig. 5. Macrophages migrate to high concentrations of complement component C5a at the lesion epicenter via purinergic receptors. (A) Representative images 
of the immunohistochemical analysis of the spatiotemporal distribution of CD68 (green) and C5a (white) in the injured cord after SCI. The C5a+ area was located medial-
ly in the CD68+ area. (B) The C5a expression patterns were dependent on the distance from the lesion epicenters. The C5a expression gradient was observed at 4 and 7 
dpi, and the expression of C5a peaked at the lesion epicenter at 7 dpi (n = 8 samples from eight mice/each group/each time point). (C) Representative images of the im-
munohistochemical analysis of the injured spinal cord obtained from WT mice daily injected with C5a rostral and caudal to the lesion epicenter from 4 to 7 dpi. CD68+ 
macrophages were attracted to the C5a injection sites. The arrowheads indicate the injection sites of PBS or C5a. (D) A comparison of the craniocaudal distribution of 
macrophages between the C5a- and PBS-injected spinal cord at 7 dpi (n = 8 samples from eight mice per group). (E) Time-lapse phase-contrast microscopy image 
sequences of macrophages in the C5a gradient. WT macrophages migrated toward higher concentrations of C5a, whereas IRF8−/− macrophages did not migrate when 
exposed to a C5a chemotactic gradient. (F) Migration plots of WT (black dots and lines) and IRF8−/− (red dots and lines) macrophages in a gradient of C5a. The starting 
point of each track was normalized to the position x = 0 and y = 0. The positive values on the y axis represent movement in the direction of the source of C5a (n = 18 per 
group). (G) Mean velocities of WT and IRF8−/− macrophages treated with C5a (n = 18 per group). (H) Mean chemotaxis indices of WT and IRF8−/− macrophages treated with 
C5a (n = 18 per group). (I) mRNA expression in the isolated WT and IRF8−/− macrophages (n = 6 samples per group). (J) Representative images of the immunohistochemical 
analysis of the CD68 macrophages after blockade of purinergic signaling in the injured cord. Inhibitors of purinergic receptors or PBS were injected every other day from 
4 dpi. (K) Quantitative analysis of craniocaudal range of CD68+ macrophages with PBS injection (control), triple block, or cocktail block (n = 10 samples from 10 mice per 
group). The images shown in (A) and (C) are representative of eight slides from eight mice per group or time point. Scale bars, 500 m. *P < 0.05 and **P < 0.005, Wilcoxon 
rank-sum test (D, G, H, and I) and two-way repeated-measures ANOVA with the Tukey-Kramer post hoc test (K). The data are presented as means ± SEM.
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Fig. 6. Activating IRF8 promotes macrophage migration during the recovery phase after SCI. (A) Macrophage transplantation protocol. Using a cell sorter, IRF8- 
activated and nonactivated macrophages were isolated from injured cords at 4 and 7 dpi of EGFP+ bone marrow chimeric mice, respectively. These cells were transplanted 
into the spinal cord of EGFP− WT mice immediately after SCI. (B) Representative images of the immunohistochemical analysis of injured spinal cords transplanted with 
IRF8-activated or nonactivated macrophages. The arrowheads indicate the injection sites of macrophages. (C) Craniocaudal distribution of the transplanted IRF8-activated 
macrophages compared with the transplanted nonactivated macrophages in the injected spinal cord at 7 dpi (n = 8 sections/four mice per group). (D) Immunocytochemical 
analysis of the IRF8 translocation into the nuclei of macrophages differentiated from isolated CD11b+/CD45high/Ly6G− peripheral blood–derived monocytes 3 hours after 
IFN- and LPS combination stimulation, stained with CD68 (green), IRF8 (red), and Hoechst (blue). (E) Fluorescence ratio of nuclear IRF8 to cytosolic IRF8 (n = 30 cells per 
group). (F) mRNA expression of purinergic receptors in macrophages 3 hours after combination stimulation (n = 8 dishes per group). (G) Schedule of in vivo combination 
injection after SCI. PBS or combination was injected into the spinal cord after SCI. (H) Representative images of the immunohistochemical analysis of the injured cord 
receiving the combination injection. CD68+ macrophages with combination injection rapidly migrated toward the lesion epicenter at 4 dpi. Increased nuclear transloca-
tion of IRF8 of macrophages was shown in the injured cord with combination injection. Scale bars, 500 m (left) and 10 m (right). (I) Ratio of nuclear IRF8 to cytosolic IRF8 
of macrophages in the injured cord with PBS or combination injection at 4 dpi (n = 30 cells from eight slides per eight mice per group). (J) Time course of macrophage 
migration in the injured cord with the combination injection. (K) Comparison of the craniocaudal distribution of WT/IRF8−/− macrophages with combination injection and 
those with PBS injection (n = 8 per group per time point). (L) Representative images of the immunofluorescent staining of spinal cord with PBS/combination injection at 
14 dpi. (M) Quantification of the 5HT+ area of spinal cord with PBS/combination injection at 14 dpi (eight sections/eight mice per group). (N) BMS score of WT mice with 
PBS or combination injection (n = 8 mice per group). (O) Footprint analysis of WT/IRF8−/− mice with combination injection compared to those with PBS injection at 14 dpi. 
(P) Stride length of WT/IRF8−/− mice with PBS and combination injection at 14 dpi (n = 14 mice per group). (Q) Scores of the grip walk test in each mouse at 14 dpi (n = 14 
per group). Scale bars, 500 m (B and J), 10 m (D), and 100 m (L). The images shown in (H), (J), and (L) are representative of eight slides from eight mice/each group per 
time point. *P < 0.05 and **P < 0.005, Wilcoxon rank-sum test (E, F, I, and M), ANOVA with the Tukey-Kramer post hoc test (C, K, P, and Q) and two-way repeated- measures 
ANOVA with the Tukey-Kramer post hoc test (N). The data are presented as means ± SEM. (C, F, K, M, N, P, and Q).
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A and B). The combination injection successfully activated mac-
rophagic IRF8 with enhanced nuclear translocation (Fig. 6, H and I). 
The mice with the combination injection showed greater promotion 
of macrophage migration than those with PBS injection, accompa-
nied by a significantly large 5HT+ axonal area (Fig. 6, J to M, and fig. 
S19C). Subsequently, the motor functional recovery with combi-
nation injection was significantly improved compared with those 
with PBS injection, but neither promoted macrophage migration 
nor improved functional recovery was observed in combination- injected 
IRF8−/− mice (Fig. 6, J, K and O to Q). These results indicated that the 
combination promoted IRF8 activation with accelerated macro-
phage migration into the smaller area during the recovery phase, 
leading to greater sparing of 5HT+ fibers and better functional 
recovery.
DISCUSSION
In this study, we performed a time-course RNA-seq analysis and 
identified IRF8 as a contributing factor for SCI recovery. With time- 
lapse imaging and a histopathological analysis, we revealed that IRF8 
was necessary for macrophage-autonomous migration toward high 
C5a concentrations through the IRF8-purinergic receptor axis, sig-
nificantly influencing the tissue pathology and functional recovery 
after SCI. Promoting IRF8 activation enhanced macrophage cen-
tripetal migration, leading to improved functional recovery after 
SCI. These findings shed light on the importance of IRF8-dependent 
macrophage migration for neurological recovery, raising a possibility 
of a novel therapeutic strategy for SCI.
Infiltrating macrophages after SCI are considered to have bene-
ficial and detrimental effects. Infiltrating blood-derived macrophages 
in the lesion epicenter expressed CD11c and had beneficial effects 
on functional and physiological recovery after SCI (34). IRF8−/− 
macrophages that did not reach the epicenter might not express 
CD11c and have less beneficial effect, leading to worse functional 
recovery in mice with IRF8−/− macrophages. Detrimental effects of 
macrophages such as promotion of forming scars, damaging axons, 
and decreasing spared myelin were also shown in several studies 
using clodronate liposomes for depletion of infiltrating macrophages 
after SCI (35–37). IRF8−/− macrophages widely scattered in injured 
spinal cord during recovery phase might exert these detrimental ef-
fects on a larger range of spinal cord, resulting in poor functional 
recovery after SCI. Our results indicate negative correlations between 
the ranges of macrophages in injured cord and the LFB+ areas or 
GFAP−  area (Fig. 4F and fig. S5). Given that the numbers of infiltrating 
macrophages in WT and IRF8−/− mice after SCI are comparable, 
these results provide a new concept that not only the numbers but 
also the location of infiltrating macrophages affect remyelination 
and formation of glial scar. Together, there is a possibility that 
IRF8−/− macrophages with impaired centripetal migration may not 
express CD11c having less beneficial effects at epicenter and that 
widely spread IRF8−/− macrophages have a detrimental effect over 
larger areas on injured spinal cord.
In this study, the combination injection of IFN- and LPS sig-
nificantly activated IRF8, but these two molecules would not exist in 
injured spinal cord without virus or Gram-negative bacteria. Regard-
ing the upstream of IRF8, juxtacrine Jagged1/Notch1 signaling was 
recently reported to activate IRF8 (38, 39). Macrophages express 
Jagged1 and Notch1 after CNS injury (40), and we confirmed the 
increased expressions of Jagged1 and Notch1 in the injured cord 
(fig. S20A). However, the Hes1 (target gene of Notch signaling) ex-
pression was significantly decreased in macrophages, indicating 
that Notch signaling was unlikely to be upstream of the IRF8 axis in 
macrophages after SCI (fig. S20B). We next focused on Toll-like 
receptor 4 (TLR4) signaling, which is known to induce IRF8 target 
gene expression in macrophages (31). After SCI, necrotizing cells 
release damage-associated molecular patterns (DAMPs), such as heat 
shock proteins, high-mobility group box 1 protein, fibronectin and 
soluble hyaluronan (41), and all of which are potential TLR4 ligands 
that can activate IRF8 signaling (42, 43). We observed a marked in-
crease in the TLR4 expression on macrophages, suggesting the 
significance of the DAMP/TLR4/IRF8 pathway for macrophage mi-
gration after SCI (fig. S20C).
In an in vitro assay, cultured primary IRF8-deficient microglia 
derived from the brain show impaired motility accompanied by de-
creased purinergic receptor expressions, but the relevance of this 
finding to CNS diseases is not known (44). In our study, microglial 
IRF8–deficient chimeric mice showed that microglial IRF8 has no 
significant effect on SCI pathology, while purinergic receptors expressed 
in peripheral blood–derived macrophages via IRF8 caused C5a-directed 
centripetal migration and significantly affected SCI pathology. These 
findings demonstrate the possible treatment by enhancing migration 
of macrophages (Fig. 6 and fig. S2). As Masuda et al. (44), Davalos et al. (45), 
and Haynes et al. (46) described, microglia in vivo may have diffi-
culty to migrate because of the tight cell adhesion in the tissue after 
injury, which may be a reason why microglial IRF8 did not significantly 
affect SCI pathology. These findings suggest the possibility that mi-
croglia changes the cell adhesion and motility depending on the sur-
rounding environment by a different mechanism from macrophages.
After IRF8 activation, the macrophages migrated within the C5a 
gradient (Fig. 5). Regarding the etiology of the C5a gradient, several 
possible sources may be involved in the injured spinal cord. Imme-
diately after SCI, hemorrhaging and neutrophil infiltration occur at 
the injury site with blood–spinal cord barrier disruption (4, 47). In 
this phase, massive C5a flows directly into the lesion area from the 
peripheral blood, and infiltrating neutrophils also produce C5a 
(fig. S21A) (47). In addition, the pericytes that increase in number 
at the center of the lesion after SCI may also express C5a (fig. S21B) 
(48, 49). Furthermore, macrophages themselves also expressed C5a 
after migrating near the epicenter (fig. S21C). As a consequence, a 
C5a gradient was orchestrated around the lesion, gradually guiding 
the macrophages to the epicenter. Roach et al. (50) discovered that 
C5a binds to G protein–coupled receptors of macrophages and in-
creases intercellular concentration of Ca2+ via PLC3 dependent on 
Gi. Considering that the increase of Ca2+ intracellular concentration 
causes the exocytosis of ATP, released ATP by exocytosis via the C5a– 
G protein coupling receptor–PLC3 axis could bind to purinergic re-
ceptors, leading to promote macrophagic migration (51, 52).
Among the C5a gradient, WT macrophages migrated to epicenter 
leading to the remyelination, while IRF8−/− macrophages remain 
widely spread over the lesion with the large demyelinated area after 
SCI (Figs. 3 and 5). This profound demyelination at 42 dpi might be 
due to possible severe initial demyelination caused by acute inflam-
mation after SCI (4). However, there were no significant differences 
in cell numbers and inflammatory cytokine expression levels be-
tween WT and IRF8−/− macrophages (Fig. 3, A and B, and figs. S1 
and S13 to S15). Although IRF8 was suggested to be involved with 
inflammation in certain environments (39), considering that inflam-
matory cytokine expression in infiltrating macrophages peaked around 
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12 hours after SCI and thereafter notably decreased at 4 and 7 dpi 
(24), IRF8 that activates after 7 dpi could not regulate these inflam-
matory cytokines after SCI (Fig. 2B). With the comparable inflam-
matory reaction, IRF8−/− mice showed similar initial demyelinated 
area in acute phase compared with WT mice, indicating that the large 
demyelinated area in IRF8−/− mice at 42 dpi was due to impaired 
remyelination process (fig. S5).
After SCI, axons in spinal tracts retract away from the injury site, 
and this deleterious phenomenon is known as axonal dieback (53). 
Since the spared axon is indispensable for the remyelination process, 
which is important for functional recovery, reducing axonal dieback 
could be a promising therapeutic strategy for SCI (22). As the primary 
mechanism of the axonal dieback, it was demonstrated that macro-
phages in contact with axons caused the axonal dieback via macrophage- 
derived matrix metalloproteinases (7). In vivo time-lapse multiphoton 
imaging showed that this macrophage-mediated axonal dieback 
occurs in the area where infiltrating macrophages were present un-
til at least 3 weeks after SCI (8). Considering that the combination 
injection facilitated the macrophage migration to the compacted 
area over this time period, the larger amount of axons escaped from 
the contact with macrophages as well as the axonal dieback, result-
ing in the improved functional recovery in the treatment group 
(Fig. 6, G to Q). IFN- is therapeutically used for patients with renal 
cancer, chronic granulomatous disease, and Sézary syndrome, and 
LPS is also used in infection prevention (54–57). We also confirmed 
that there was no detrimental effect with the combination using 
IFN- and LPS in the subacute phase of SCI (fig. S19, A and B), 
suggesting the high feasibility of this novel therapeutic strategy via 
IRF8 activation (31).
Although the distribution of IRF8−/− macrophages was wider than 
that of WT macrophages, some macrophages were near the epicenter 
at 14 and 42 dpi (Fig. 3, C and E). This suggests the possibility that, 
in addition to IRF8, other molecules might be also involved in mi-
gration of macrophages in the injured spinal cord. Following this 
study, to discover and investigate these molecules would lead to a 
better understanding of the mechanism underlying macrophage 
migration after SCI.
In conclusion, we demonstrated that lack of epicenter-directed 
macrophage migration led to worse functional recovery after SCI.
IRF8 drives macrophage migration toward C5a, regulating the 
purinergic receptor expression. Our findings provide deeper insight 
into the role of macrophage centripetal movement in spontaneous 
recovery, providing the therapeutic potential of promoting infiltrating 
cell migration toward the lesion epicenter after traumatic CNS injury.
MATERIALS AND METHODS
Animals
All study protocols involving mice were approved by the Committee 
of Ethics on Animal Experimentation of our institution and con-
ducted in accordance with the National Institutes of Health guide-
lines for the care and use of animals. All mice were housed in a 
temperature- and humidity-controlled environment on a 12-hour 
light-dark cycle and food/water available ad libitum. IRF8−/− and 
Nes-EGFP+ mice were generated as described previously (9, 17). To 
generate IRF8−/−;EGFP+ mice, we crossed IRF8−/− and CAG-EGFP 
mice. Bone marrow transplantation was performed as previously 
described (20). Eight-week-old female C57BL/6 J mice were used as 
WT mice. Microglial IRF8–deficient chimeric mice were generated 
by transferring the bone marrow cells (BMCs) of EGFP+ IRF8+/+ 
mice into IRF8−/− recipient mice, and macrophagic IRF8–deficient 
chimeric mice were generated by transferring the BMCs of EGFP+ 
IRF8−/− mice into WT recipient mice after irradiation, as previously 
described (20). Accordingly, the former mice consisted of EGFP+ 
IRF8+/+ macrophages and EGFP− IRF8−/− microglia, while the latter 
consisted of EGFP+ IRF8−/− macrophages and EGFP− IRF8+/+ mi-
croglia. In these chimeric mice, macrophages were distinguished 
from microglia by their potent EGFP expression. [EGFP+ macro-
phages: IRF8+/+]/[EGFP− microglia: IRF8+/+] mice were generated 
by transferring EGFP+ IRF8+/+ BMCs into IRF8+/+ recipient mice, 
and [EGFP+ macrophages: IRF8−/−]/[microglia: IRF8+/+] mice were 
generated by transferring EGFP+ IRF8−/− BMCs into IRF8+/+ mice.
Spinal cord injury
The mice were anesthetized with pentobarbital (75 mg/kg intraperi-
toneally) and subjected to a contusion injury (70 kilodynes) at the 
10th thoracic level using an Infinite Horizons Impactor (Precision 
Systems Instrumentation) (15). After injury, the overlying muscles 
were sutured, and the skin was closed with wound clips. During the 
period of recovery from anesthesia, the animals were placed in a 
temperature-controlled chamber until thermoregulation was re-
established. The motor function was evaluated according to a loco-
motor open-field rating scale, the BMS (58). A footprint analysis was 
performed as previously described (24). The forelimbs and hindlimbs 
of the mice were dipped in red and green dyes, respectively. For the 
grip walk test, each mouse was evaluated using 50 cm of the grid 
with three patterns: easy (50 steps, 1 cm apart), medium (every third 
step removed), and hard (every other step removed) (25). The sum 
of the number of grips for all three patterns was used in the analysis. 
A team of two experienced examiners evaluated the score of each 
animal in a blinded fashion (32).
C5a injection
A glass tip was inserted 2 mm rostral and caudal from the epicenter 
of the injured spinal cord, and 2 l of 1 M mouse recombinant C5a 
(R&D Systems) was injected at 0.5 l/min using a stereotaxic injector 
(KDS 310, Muromachi Kikai) from 4 to 7 dpi (14). Control animals 
received 2 l of PBS from 4 to 7 dpi.
Macrophage transplantation
Using flow cytometry, macrophages with or without IRF8 activa-
tion were obtained from the injured spinal cord of bone marrow 
chimeric mice [EGFP+ macrophages: IRF8+/+]/[microglia: IRF8+/+] 
at 7 or 4 dpi. EGFP+ cells (5.0 × 105) were transplanted into the 
injured spinal cord of WT mice immediately after SCI using a glass 
micropipette and a stereotaxic injector, as described previously 
(KDS 310, Muromachi Kikai) (6). Injections were performed bilat-
erally at four sites of intact parenchyma 1.5 mm rostral and caudal 
to the epicenter.
Combination administration
Injured mice received an injection of 2 g of recombinant murine 
IFN- (PeproTech) and 200 ng of LPS (Sigma-Aldrich) at the epi-
center using a stereotaxic injector (KDS 310, Muromachi Kikai) 
every 2 days from 2 dpi. For in vitro combination administration, 
10 ng of IFN- and 100 ng of LPS were added to macrophages (4.0 × 
104/ml) differentiated from WT CD11b+/Ly6G−/CD45high peripheral 
blood–derived monocytes after cultivated for 4 days as previously 
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described (59), and an immunocytochemical analysis and mRNA ex-
traction were performed at 3 hours after stimulation, respectively. The 
paw withdrawal threshold was analyzed as previously described (19).
In vivo cocktail block
Injured mice received an injection of 10 M AR-C69931MX (R&D 
Systems), 10 M AR-C 118925XX (R&D Systems), 100 M 8-SPT 
(Santa Cruz Biotechnology), 100 M MRS-2179 (Cayman Chemical), 
and 300 nM NF-449 (Cayman Chemical) at the epicenter using a 
stereotaxic injector every 2 days from 4 to 14 dpi.
Histopathological examination
The animals were reanesthetized and transcardially fixed with 
4% paraformaldehyde. The spinal cord was removed, dehydrated, and 
embedded in an optimal cutting temperature compound, and fro-
zen sections were cut on a cryostat in the sagittal plane at 14 mm. 
The sections were subsequently stained with primary antibodies at 
4°C overnight and then incubated with Alexa Fluor secondary anti-
bodies (1:200; Invitrogen) and Hoechst 33258. LFB-stained serial 
sections were evaluated as previously described (4, 9, 15). The R.T.U. 
(Ready-to-Use) Vectastain kit (Vector Laboratories) was used for CD68 
staining (15). The following primary antibodies were used: CD68 
(rat, MCA1957; 1:200; Serotec), GFAP (rabbit, Z0334; 1:200; Dako), 
IRF8 (goat, sc-6058; 1:200; Santa Cruz Biotechnology), GST- 
(mouse, no. 610719; 1:200; BD Biosciences), NeuN (mouse, MAB377; 
1:200; Chemicon), PMN (rat, MCA771GA; 1:200; Serotec), CD3 
(145-2C11; 1:200; eBioscience), 5-HT (goat, no.20079; 1:200; ImmunoStar), 
platelet-derived growth factor receptor- (PDGFR) (rat, no.136002; 
1:200; BioLegend), and C5a (rabbit, BS-0324R; 1:200; Bioss). In-
filtrating macrophages change their morphology to the amoeboid form 
in injured tissue (4, 60, 61). The range of morphologically amoe-
boid CD68 macrophages and 5HT+ area was measured using 
the BZ-II analyzer software program (Keyence). All images were 
captured using a BZ-9000 digital microscope system (Keyence), 
EVOS microscope (Life Technologies), or epifluorescence microscope 
equipped with a digital camera (BX51, Olympus).
Flow cytometry
The spinal cords (6.0 mm in length, centered around the lesion) 
were dissociated in collagenase type I (Invitrogen) and stained with 
antibodies, as previously described (4). The samples were analyzed 
using a FACSAria II flow cytometer and the FACSDiva software 
program (BD Biosciences). The following antibodies were used: PE-
Cy7–conjugated CD45 (30-F11; 1:10), APC-conjugated CD11b 
(M1/70; 1:10), fluorescein isothiocyanate–conjugated CD11b (M1/70; 
1:10), APC-conjugated CD11b (M1/70; 1:10), PE-conjugated Ly6G 
(1A8; 1:50), APC-conjugated Ly6C (HK1.4; 1:10), PE-conjugated 
F4/80 (BM8; 1:10), biotin-conjugated CD115 (AFS98; 1:10), and 
Streptavidin-PerCP-Cyanine5.5 (45-4317-80; 1:10). All conjugated 
antibodies were purchased from eBioscience. CD45 is a marker of 
myeloid cells. In the injured spinal cord, infiltrating macrophages 
are divided into CD45high population (4). CD11b is a marker for mac-
rophages, monocytes, and neutrophils (4). Ly6G is a marker for neu-
trophils (6). We isolated CD11bhigh/Ly6Gnega/CD45high population 
as infiltrating macrophages (4, 6, 15). Ly6C is a marker for a subset 
of macrophages (6, 18). CD115 is a marker for monocytes (18). We 
isolated EGFP+/CD11bposi/Ly6Gnega/CD115posi population as pe-
ripheral blood–derived monocytes from EGFP+ bone marrow chi-
meric mice. Reactive astrocytes isolated from the spinal cords of 
Nes-EGFP+ mice were used as the EGFP+ population. Isolated mac-
rophages or reactive astrocytes were either subjected to RNA ex-
traction or incubated in Dulbecco’s modified Eagle’s medium for 
transplantation and in vitro combination administration.
Laser microdissection
As previously described (62), fresh injured spinal cords were imme-
diately frozen in dry ice/hexane and stored in a deep freezer at −80°C.
The tissues were sectioned into 16-m-thick slices using a cryostat 
at −20°C and were mounted on polyethylene naphthalate (PEN) 
membrane slides. The sections were then fixed in ice-cold acetone 
for 2 min. Astrocytes were obtained from injured spinal cords of 
Nes-EGFP+ mice, which have EGFP+-reactive astrocytes after SCI 
as described previously (9). For neurons, sections were fixed for 
10 s in 75% EtOH, stained for 30 s in 4% cresyl violet acetate/0.3% 
acetic acid, and dehydrated in graded solutions of ethanol (70, 95, and 
100%), followed by 45 s in xylene (63). EGFP+ astrocytes or stained 
neurons were dissected with an LMD 6500 system (Leica Microsys-
tems) and were transferred by gravity into a microcentrifuge tube 
cap placed directly beneath the section. The tube cap was filled with 
75 l of buffer RLT (Qiagen). For each sample, 500 cells were dis-
sected from one series of sagittal sections.
Quantitative RT-PCR
Total RNA was isolated from the macrophages obtained from the 
spinal cord tissue using the RNeasy Micro Kit (Qiagen) or from the 
injured spinal cord (4 mm or 500 m in length) using the RNeasy 
Mini Kit (Qiagen). The total RNA of reactive astrocytes and neurons 
was selectively isolated with LMD as previously described (14, 62, 63). 
For the complementary DNA synthesis, a reverse transcription re-
action was performed using PrimeScript Reverse Transcriptase 
(Takara). qPCR was performed using primers specific to the genes 
of interest (table S1) and SYBR Premix DimerEraser (Takara). The 
data were normalized to the expression level of glyceraldehyde- 
3-phosphate dehydrogenase.
RNA sequencing
The sample preparation and data analysis were performed as de-
scribed previously (64). Briefly, the mRNA sequencing library was 
prepared using the NEBNext Ultra Directional Library Prep Kit for 
Illumina (New England Biolabs), and the samples were sequenced 
on an Illumina HiSeq 1500 system. The gene expression levels (FPKM) 
were calculated using the TopHat (version 2.0.11) and Cufflinks 
(version 2.1.1) software programs with default parameters (16). An 
enrichment analysis for the biological processes was performed based 
on the GO database annotations with DAVID (65). The calculated 
−ln(P values) were displayed on the x axis of the graph.
Chemotaxis assays
Time-lapse imaging of WT and IRF8−/− macrophages was performed 
as described previously (28). Briefly, macrophages obtained from 
WT or IRF8−/− mice were labeled with PE-conjugated F4/80 
(a marker for mouse macrophages) antibody, and F4/80+ cells 
were isolated using FACSAria II. These macrophages were 
resuspended in 100 to 150 l of RPMI 1640 containing bicarbonate 
and 10% fetal calf serum (FCS), and 8 l of the suspension was 
seeded into the narrow channel of an uncoated (ibiTreat) -slide 
chemotaxis chamber (Ibidi) placed in a humidified incubator 
(at 37°C with 5% CO2). This narrow channel (observation area) 
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connects two 40-ml reservoirs. In the chemotaxis experiments, 
bicarbonate-free RPMI 1640 containing 20 mM Hepes (Biochrom 
AG) and 10% FCS was used. A final concentration of 10 nM 
mouse recombinant C5a was added to one of the reservoirs, and 
the cells were imaged by phase-contrast microscopy. Images were 
captured every 10 min for 18 hours, and the cell migration tracks 
between 8 and 18 hours were analyzed using the ImageJ software 
program (National Institutes of Health) with a manual tracking 
plug-in and the chemotaxis and migration tool from Ibidi. Eigh-
teen randomly selected cells were tracked in each chemotaxis 
experiment.
Statistical analysis
The Wilcoxon rank-sum test was used to compare the medians of 
the data for qPCR as well as the cell count, craniocaudal range of 
macrophages, and functional outcome score. For multiple compar-
isons in qPCR, Dunnett’s test was applied. For the analysis of the 
differences in the BMS scores between the groups over time, a two-
way repeated-measures ANOVA with post hoc Tukey’s test was 
performed. For the comparative analysis of three or more groups, a 
one-way ANOVA with post hoc Tukey’s test was performed. All 
tests were two sided, and the level of significance was set at 0.05. The 
values for groups were presented as the average ± SEM. All statis-
tical analyses were carried out using the JMP software program 
(version 13; SAS Institute).
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